The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126056061 12605606 1 I 20100310 20110311 20160729 20160729 EXP US-ROCHE-772082 ROCHE 61.35 YR F Y 76.40000 KG 20160729 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126056061 12605606 1 PS Vismodegib VISMODEGIB 1 Oral 150 MG, QD CYCLE 21 DAYS, COURSE 1 7200 MG U NOT REPORTED 203388 CAPSULE QD
126056061 12605606 2 SS Vismodegib VISMODEGIB 1 Oral COURSE 2 7200 MG U NOT REPORTED 203388 CAPSULE
126056061 12605606 3 SS Vismodegib VISMODEGIB 1 Oral COURSE 3 7200 MG U NOT REPORTED 203388 CAPSULE
126056061 12605606 4 SS Vismodegib VISMODEGIB 1 Oral COURSE 4 7200 MG U NOT REPORTED 203388 CAPSULE
126056061 12605606 5 SS Vismodegib VISMODEGIB 1 Oral COURSE 5 7200 MG U NOT REPORTED 203388 CAPSULE
126056061 12605606 6 SS CISPLATIN. CISPLATIN 1 Intravenous (not otherwise specified) 75 MG/M2, Q21D U 0 75 MG/M**2
126056061 12605606 7 SS ETOPOSIDE. ETOPOSIDE 1 Intravenous (not otherwise specified) 100 MG/M2, QDX3D/21DC U 0 100 MG/M**2
126056061 12605606 8 C EMEND APREPITANT 1 0
126056061 12605606 9 C ALOXI PALONOSETRON HYDROCHLORIDE 1 0
126056061 12605606 10 C DECADRON DEXAMETHASONE 1 0
126056061 12605606 11 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Unknown UNK 0 QD
126056061 12605606 12 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Unknown 0
126056061 12605606 13 C ATIVAN LORAZEPAM 1 Unknown UNK 0 QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126056061 12605606 1 Small cell lung cancer
126056061 12605606 6 Small cell lung cancer
126056061 12605606 7 Small cell lung cancer
126056061 12605606 8 Premedication
126056061 12605606 9 Premedication
126056061 12605606 10 Premedication
126056061 12605606 11 Product used for unknown indication
126056061 12605606 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126056061 12605606 OT
126056061 12605606 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126056061 12605606 Abdominal infection
126056061 12605606 Abdominal pain
126056061 12605606 Colitis
126056061 12605606 Decreased appetite
126056061 12605606 Enterocolitis infectious
126056061 12605606 Headache
126056061 12605606 Hyponatraemia
126056061 12605606 Hypophosphataemia
126056061 12605606 Nausea
126056061 12605606 Neutrophil count decreased
126056061 12605606 Oesophageal spasm
126056061 12605606 Vomiting
126056061 12605606 Weight decreased
126056061 12605606 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126056061 12605606 1 20100310 20100511 0
126056061 12605606 5 20100623 20100708 0
126056061 12605606 12 20100317 20100319 0